IMPACT BIOMEDICAL INC (IBO) Stock Balance Sheet
USA - NYSEARCA:IBO - US45259L2051 - Common Stock
0.5802 USD
0 (-0.65%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 624.00K | 2.00M | 1.00K | 2.00K | 46.00K | |||
| Receivables | 200.00K | 184.00K | 331.00K | 16.00K | 197.30K | |||
| Inventories | 486.00K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 171.00K | 265.00K | 0.00 | 104.00K | 43.60K | |||
| Total Current Assets | 1.48M | 2.45M | 332.00K | 122.00K | 286.90K | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.00K | 17.00K | 287.00K | 276.00K | N/A | |||
| Investments And Advances | N/A | N/A | 0.00 | 782.00K | 4.82M | |||
| Goodwill | 0.00 | 0.00 | 25.09M | 25.09M | 25.09M | |||
| Intangibles | 17.57M | 17.81M | 18.92M | 20.03M | 21.15M | |||
| Total Non-Current Assets | 17.58M | 17.84M | 44.30M | 46.38M | 56.14M | |||
| TOTAL ASSETS | 19.06M | 20.29M | 44.63M | 46.50M | 56.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 22.35M | 8.88M | 12.07M | 9.99M | 12.52M | |||
| Accrued Expenses | 266.00K | 194.00K | 230.00K | 63.00K | 5.40K | |||
| Accounts Payable | 554.00K | 713.00K | 832.00K | 539.00K | 115.10K | |||
| Total Current Liabilities | 23.17M | 9.79M | 13.14M | 10.59M | 12.64M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 3.27M | 3.27M | 3.23M | 3.23M | 3.86M | |||
| Total Non-Current Liabilities | 6.23M | 6.25M | 6.28M | 6.35M | 7.17M | |||
| TOTAL LIABILITIES | 29.40M | 16.03M | 19.41M | 16.94M | 19.82M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -53.28M | -37.67M | -12.96M | -8.63M | -1.57M | |||
| Additional Paid In Capital | 42.87M | 41.86M | 38.11M | 38.11M | 38.06M | |||
| Minority Interest | 2.96M | 2.98M | 3.04M | 3.11M | 3.32M | |||
| Common Shares | 72.00K | 71.00K | 70.00K | 70.00K | 125.10K | |||
| Shares Outstanding | 12.19M | 11.50M | 11.50M | 11.50M | 11.50M | |||
| Tangible Book Value per Share | -2.29 | -1.18 | -1.64 | -1.35 | -0.84 | |||
| Total Shareholders' Equity | -10.34M | 4.26M | 25.22M | 29.56M | 36.61M | |||
| TOTAL LIABILITIES AND EQUITY | 19.06M | 20.29M | 44.63M | 46.50M | 56.42M | |||
| Statistics | ||||||||
| Current Ratio | 0.06 | 0.25 | 0.03 | 0.01 | 0.02 | |||
| Return On Assets (ROA) | -201.86% | -121.77% | -9.71% | -15.16% | -2.31% | |||
| Return On Equity (ROE) | N/A | -580.14% | -17.19% | -23.85% | -3.56% | |||
All data in USD , ROIC based on taxRate of 0.21